Skip to main content
Home
Latest news
Browse topics
Lupus Rheumatoid arthritis Spondyloarthropathies COVID-19 Browse all topics
In focus
Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA Anifrolumab for the treatment of SLE JAK inhibitor safety: Weighing up the data and understanding the risks Rituximab and rheumatology practice in the COVID-19 era Safety snapshot: Upadacitinib in patients with PsA Repurposing rheumatology drugs for COVID-19 Telemedicine in rheumatology: COVID-19 and beyond Managing PsA in resource-limited settings
Conferences
ACR Convergence 2022 EULAR 2022 Congress
About us
Medicine Matters Rheumatology
EXTENDED SEARCH
7 search results for:

Allopurinol hypersensitivity syndrome 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 30-10-2017 | Image

    Figure 2: Time elapsed (in days) from the start of allopurinol treatment to the occurrence of allopurinol hypersensitivity syndrome in patients with gout. [27]
  2. 25-04-2018 | Gout | News | Article

    Ethnicity may be a risk factor for allopurinol hypersensitivity

    People of Black, Asian, or Native Hawaiian/Pacific Islander ethnicity have a substantially higher risk for allopurinol-associated severe cutaneous adverse reactions than White and Hispanic individuals, US researchers report.

    Published in:
    Ann Rheum Dis 2018; Advance online publication
  3. 21-06-2018 | Gout | Review | Article

    Predicting response or non-response to urate-lowering therapy in patients with gout

    The authors review the extent of treatment success or failure with the xanthine oxidoreductase inhibitors allopurinol and febuxostat and indicate how the dosage of urate-lowering therapy may be modified to increase the response in the majority of patients with gout. Graham GG et al. Curr Rheumatol Rep 2018; 20: 47. doi: 10.1007/s11926-018-0760-2

  4. 21-06-2018 | Gout | Highlight | Teaser
    Journal article

    Predicting response or non-response to urate-lowering therapy in patients with gout

    The authors review the extent of treatment success or failure with the xanthine oxidoreductase inhibitors allopurinol and febuxostat and indicate how the dosage of urate-lowering therapy may be modified to increase the response in the majority of patients with gout [ read more ]. Graham GG et al. Curr Rheumatol Rep 2018; 20: 47. doi: 10.1007/s11926-018-0760-2

  5. 13-04-2018 | Allopurinol hypersensitivity syndrome | Article

    Racial/ethnic variation and risk factors for allopurinol-associated severe cutaneous adverse reactions: a cohort study

    Keller SF et al. Ann Rheum Dis 2018; Advance online publication. doi: 10.1136/annrheumdis-2017-212905

  6. 08-09-2016 | Gout | Article

    Comparative efficacy and safety of urate-lowering therapy for the treatment of hyperuricemia: a systematic review and network meta-analysis

    However, patients taking allopurinol have a high risk of serious hypersensitivity syndromes, such as Stevens-Johnson syndrome and toxic epidermal necrolysis, which may have a strong association with the HLA-B*5801 allele, a genetic change more commonly observed in Asian populations 19,54 .

    Author:
    Shu Li, Hongxi Yang, Yanan Guo, Fengjiang Wei, Xilin Wang, Daiqing Li, Mingzhen Li, Weili Xu, Weidong Li, Li Sun, Ying Gao, Yaogang Wang
  7. 29-09-2015 | Gout | Article

    Allopurinol hypersensitivity: investigating the cause and minimizing the risk

    This review examines allopurinol hypersensitivity, with a focus on risk factors and mechanisms, in the context of reducing the risk of this rare, but serious, adverse reaction. Nat Rev Rheumatol . 2016;12:235–242. doi: 10.1038/nrrheum.2015.132.

    Author:
    Lisa K. Stamp, Richard O. Day, James Yun
  • 1

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.